Thursday, April 6, 2023

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

 https://pubmed.ncbi.nlm.nih.gov/35070575/

No comments: